Clinicopathological characterization of TSH-producing adenomas: Special reference to TSH-immunoreactive but clinically non-functioning adenomas

Endocrine Pathology

Volumn 20, Issue 4, 2009, Pages 209-220

  Wang, Elaine Lu ^a   Qian, Zhi Rong ^a   Yamada, Shozo ^b   Rahman, Md Mustafizur ^a   Inosita, Naoko ^b   Kageji, Teruyoshi ^a   Endo, Hideko ^a   Kudo, Eiji ^a   Sano, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

GATA2; Pit 1; Silent TSH adenoma; SSTR; TSH producing adenoma

Indexed keywords

ANTITHYROID AGENT; BROMOCRIPTINE; CABERGOLINE; GROWTH HORMONE; OCTREOTIDE; PROLACTIN; RADIOACTIVE IODINE; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR PIT 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NAUSEA; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROIDECTOMY; THYROTROPIN SECRETING ADENOMA; TSH SECRETING CELL; TUMOR CELL; TUMOR VOLUME; VERTIGO; VISUAL DISORDER;

ADENOMA; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GATA2 TRANSCRIPTION FACTOR; HEADACHE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; NAUSEA; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROTROPIN; TRANSCRIPTION FACTOR PIT-1; VERTIGO; VISION DISORDERS;

EID: 70449526195     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-009-9094-y     Document Type: Article

References (32)

1. JW Jailer DA Holub 1960 Remission of Graves' disease following radiotherapy of a pituitary neoplasm Am J Med 28 497 500 10.1016/0002-9343(60) 90181-9 1:STN:280:DyaF3c7lvFWlsQ%3D%3D 14406535
2. S Holck UM Wewer R Albrechtsen 1988 Heterogeneity of secretory granules of silent pituitary adenomas Mod Pathol 3 212 215
3. HM Heshmati G Turpin M Kujas, et al. 1988 The immunocytochemical heterogeneity of silent pituitary adenomas Acta Neuropathol 118 533 537 1:STN:280:DyaL1c3ptFOjtQ%3D%3D (Pubitemid 18190990)
4. SL Asa LA Puy AM Lew, et al. 1993 Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas J Clin Endocrinol Metab 77 1275 1280 10.1210/jc.77.5.1275 1:STN:280:DyaK2czlvVSgsQ%3D%3D 8077321 (Pubitemid 23345482)
5. T Tateno H Izumiyama M Doi, et al. 2007 Differential gene expression in ACTH-secreting and non-functioning pituitary tumors Eur J Endocrinol 157 717 724 10.1530/EJE-07-0428 1:CAS:528:DC%2BD1cXksFKgsw%3D%3D 18057378
6. E Horvath K Kovacs DW Killinger, et al. 1980 Silent corticotropic adenomas of the human pituitary gland. A histologic, immunocytologic, and ultrastructural study Am J Pathol 98 617 638 1:STN:280:DyaL3c7ltFSmtg%3D%3D 6244736
7. K Kovacs R Lloyd E Horvath, et al. 1989 Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization Am J Pathol 134 345 353 1:STN:280:DyaL1M7jt1OntA%3D%3D 2464941
8. H Naritaka T Kameya Y Sato, et al. 1999 Morphological characterization and subtyping of silent somatotroph adenomas Pituitary 1 233 241 10.1023/A:1009942122673 1:STN:280:DC%2BD3M%2FlsF2nuw%3D%3D 11081203
9. O Sen ME Ertorer MV Aydin, et al. 2005 Silent pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone J Clin Neurosci 12 318 320 10.1016/j.jocn.2004.05.011 15851094 (Pubitemid 40585738)
10. AK Banerjee BS Sharma VK Kak 2000 Clinically and biochemically silent thyrotroph adenoma with oncocytic change Neurol India 48 374 377 1:STN:280:DC%2BD3M7hslKitA%3D%3D 11146605
11. T Daems J Verhelst A Michotte, et al. 2009 Modification of hormonal secretion in clinically silent pituitary adenomas Pituitary 12 80 86 10.1007/s11102-008-0085-7 1:CAS:528:DC%2BD1MXotFWjsA%3D%3D 18350381
12. Asa SL. Tumors of the pituitary gland. In: Rosai J, editor. Atlas of tumor pathology, series fascicle 22. Washington: Armed Forces Institute of Pathology. p. 109, 1998.
13. DJ Steger JH Hecht PL Mellon 1994 GATA-binding proteins regulate the human gonadotropin α-subunit gene in the placenta and pituitary gland Mol Cell Biol 14 5592 5602 1:CAS:528:DyaK2cXlslajsbY%3D 7518566
14. FG David RL Suzanne BR Lewis, et al. 1997 Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin β-subunit promoter J Biol Chem 272 24339 24347 10.1074/jbc.272.24.15553 (Pubitemid 27255586)
15. K Umeoka N Sanno RY Osamura, et al. 2002 Expression of GATA-2 in human pituitary adenomas Mod Pathol 15 11 17 10.1038/modpathol.3880484 11796836 (Pubitemid 34081454)
16. A Yoshihara O Isozaki N Hizuka, et al. 2007 Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy Endocr J 54 133 138 10.1507/endocrj.K06-133 1:CAS:528:DC%2BD2sXlsVyntL8%3D 17159301 (Pubitemid 46481681)
17. E Thodou G Kontogeorgos M Pateraki 2007 Somatostatin receptor types in TSH-producing pituitary adenomas Endocr Pathol 18 128
18. P Beck-Peccoz F Brucker-Davis L Persani, et al. 1996 Thyrotropin- secreting pituitary tumors Endocr Rev 17 610 638 1:STN:280:DyaK2s7isVygtw%3D%3D 8969971
19. E Thodou G Kontogeorgos D Theodossiou, et al. 2006 Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas J Clin Pathol 59 274 279 10.1136/jcp.2005.026914 1:STN:280:DC%2BD287hslykuw%3D%3D 16505278 (Pubitemid 43344889)
20. O De Wever P Demetter M Mareel, et al. 2008 Stromal myofibroblasts are drivers of invasive cancer growth Int J Cancer 123 2229 2238 10.1002/ijc.23925 18777559
21. N Sanno A Teramoto RY Osamura 2000 Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma J Neurosurg 93 194 200 10.3171/jns.2000.93.2.0194 1:STN:280:DC%2BD3cvhtl2rtQ%3D%3D 10930003
22. H Wang WS Li DJ Shi, et al. 2008 Correlation of MMP(1) and TIMP (1) expression with pituitary adenoma fibrosis J Neurooncol 90 151 156 10.1007/s11060-008-9647-9 1:CAS:528:DC%2BD1cXhtlamtLzE 18604474
23. E Horvath K Kovacs HS Smyth, et al. 2005 Silent adenoma subtype 3 of the pituitary-immunohistochemical and ultrastructural classification: a review of 29 cases Ultrastruct Pathol 29 511 524 10.1080/01913120500323514 1:STN:280:DC%2BD2Mnjs1CmtQ%3D%3D 16316952 (Pubitemid 41769939)
24. ZR Qian CC Li H Yamasaki, et al. 2002 Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior Mod Pathol 15 1357 1365 10.1097/01.MP.0000039572.75188.1A 12481018 (Pubitemid 35463005)
25. SW Lamberts AJ van der Lely WW de Herder, et al. 1996 Octreotide N Engl J Med 334 246 254 10.1056/NEJM199601253340408 1:CAS:528:DyaK28Xhtl2rtrw%3D 8532003 (Pubitemid 26030676)
26. B Szende AV Schally K Lapis 1991 Immunocytochemical demonstration of tissue transglutaminase indicative of programmed cell death (apoptosis) in hormone sensitive mammary tumours Acta Morphol Hung 39 53 58 1:STN:280:DyaK387gtFOktA%3D%3D 1684693
27. AV Schally 1988 Oncological applications of somatostatin analogues Cancer Res 48 6977 6985 1:CAS:528:DyaL1MXjtlOqtw%3D%3D 2903792
28. JC Reubi JA Laissue B Waser A Schonbrunn, et al. 1999 Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous system of the human gastrointestinal tract: facts and artifacts J Clin Endocrinol Metab 84 2942 2950 10.1210/jc.84.8.2942 1:CAS:528:DyaK1MXltFCltbg%3D 10443702
29. A Schonbrunn 1999 Somatostatin receptors present knowledge and future directions Ann Oncol 10 Suppl 2 17 21 10.1023/A:1027392228418
30. Y Taniyama T Suzuki Y Mikami, et al. 2005 Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study Endocr J 52 605 611 10.1507/endocrj.52.605 1:CAS:528:DC%2BD28Xjs1Cguw%3D%3D 16284440 (Pubitemid 41609051)
31. GF Taboada RM Luque W Bastos, et al. 2007 Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas Eur J Endocrinol 156 65 74 10.1530/eje.1.02313 1:CAS:528:DC%2BD2sXntlyqtbg%3D 17218727 (Pubitemid 46553904)
32. K Horiguchi M Yamada R Umezawa, et al. 2007 Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment Endocr J 54 371 378 10.1507/endocrj.K06-177 1:CAS:528:DC%2BD2sXovFGmt70%3D 17420609